These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 8884071

  • 21. Is glycation of low density lipoproteins in patients with Type 2 diabetes mellitus a LDL pre-oxidative condition?
    Moro E, Alessandrini P, Zambon C, Pianetti S, Pais M, Cazzolato G, Bon GB.
    Diabet Med; 1999 Aug; 16(8):663-9. PubMed ID: 10477211
    [Abstract] [Full Text] [Related]

  • 22. High insulin levels and increased low-density lipoprotein oxidizability in pediatric patients with systemic lupus erythematosus.
    Posadas-Romero C, Torres-Tamayo M, Zamora-González J, Aguilar-Herrera BE, Posadas-Sánchez R, Cardoso-Saldaña G, Ladrón de Guevara G, Solis-Vallejo E, El Hafidi M.
    Arthritis Rheum; 2004 Jan; 50(1):160-5. PubMed ID: 14730612
    [Abstract] [Full Text] [Related]

  • 23. Plasma lipid composition and LDL oxidation.
    Brizzi P, Tonolo G, Carusillo F, Malaguarnera M, Maioli M, Musumeci S.
    Clin Chem Lab Med; 2003 Jan; 41(1):56-60. PubMed ID: 12636050
    [Abstract] [Full Text] [Related]

  • 24. Effects of policosanol treatment on the susceptibility of low density lipoprotein (LDL) isolated from healthy volunteers to oxidative modification in vitro.
    Menéndez R, Más R, Amor AM, González RM, Fernández JC, Rodeiro I, Zayas M, Jiménez S.
    Br J Clin Pharmacol; 2000 Sep; 50(3):255-62. PubMed ID: 10971310
    [Abstract] [Full Text] [Related]

  • 25. Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels.
    Halle M, Berg A, Baumstark MW, König D, Huonker M, Keul Joseph.
    Atherosclerosis; 1999 Mar; 143(1):185-92. PubMed ID: 10208494
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia.
    Dejager S, Bruckert E, Chapman MJ.
    J Lipid Res; 1993 Feb; 34(2):295-308. PubMed ID: 8429263
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Oxidation of apolipoprotein B-100 in circulating LDL is related to LDL residence time. In vivo insights from stable-isotope studies.
    Pietzsch J, Lattke P, Julius U.
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):E63-7. PubMed ID: 11031225
    [Abstract] [Full Text] [Related]

  • 31. Gemfibrozil treatment potentiates oxidative resistance of high-density lipoprotein in hypertriglyceridemic patients.
    Chen MF, Wang TD, Yeh HT, Hsu HC, Lee YT.
    Eur J Clin Invest; 2001 Aug; 31(8):707-13. PubMed ID: 11473572
    [Abstract] [Full Text] [Related]

  • 32. Plasma remnant-like particle lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects.
    Marcoux C, Tremblay M, Fredenrich A, Jacques H, Krimbou L, Nakajima K, Davignon J, Cohn JS.
    Atherosclerosis; 1998 Jul; 139(1):161-71. PubMed ID: 9699904
    [Abstract] [Full Text] [Related]

  • 33. Apolipoprotein B carbonyl formation is enhanced by lipid peroxidation during copper-mediated oxidation of human low-density lipoproteins.
    Yan LJ, Lodge JK, Traber MG, Packer L.
    Arch Biochem Biophys; 1997 Mar 01; 339(1):165-71. PubMed ID: 9056246
    [Abstract] [Full Text] [Related]

  • 34. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
    Ooi EM, Watts GF, Sprecher DL, Chan DC, Barrett PH.
    J Clin Endocrinol Metab; 2011 Oct 01; 96(10):E1568-76. PubMed ID: 21816786
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Estrogen-induced small low density lipoprotein particles may be atherogenic in postmenopausal women.
    Wakatsuki A, Ikenoue N, Okatani Y, Fukaya T.
    J Am Coll Cardiol; 2001 Feb 01; 37(2):425-30. PubMed ID: 11216957
    [Abstract] [Full Text] [Related]

  • 38. Impaired high density lipoprotein antioxidant activity in healthy postmenopausal women.
    Zago V, Sanguinetti S, Brites F, Berg G, Verona J, Basilio F, Wikinski R, Schreier L.
    Atherosclerosis; 2004 Nov 01; 177(1):203-10. PubMed ID: 15488885
    [Abstract] [Full Text] [Related]

  • 39. Human low density lipoprotein as a target of hypochlorite generated by myeloperoxidase.
    Jerlich A, Fabjan JS, Tschabuschnig S, Smirnova AV, Horakova L, Hayn M, Auer H, Guttenberger H, Leis HJ, Tatzber F, Waeg G, Schaur RJ.
    Free Radic Biol Med; 1998 May 01; 24(7-8):1139-48. PubMed ID: 9626568
    [Abstract] [Full Text] [Related]

  • 40. Effect of ascorbate supplementation on low density lipoprotein oxidation in smokers.
    Fuller CJ, Grundy SM, Norkus EP, Jialal I.
    Atherosclerosis; 1996 Jan 26; 119(2):139-50. PubMed ID: 8808491
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.